• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

Anacor Pharmaceuticals - Articles and news items


Pfizer completes acquisition of Anacor Pharmaceuticals

Industry news / 27 June 2016 / Victoria White, Digital Content Producer

The Anacor acquisition adds crisaborole, a differentiated non-steroidal topical PDE4 inhibitor with anti-inflammatory properties, to Pfizer’s pipeline…

Anacor’s crisaborole achieves primary and secondary endpoints in two Phase 3 studies in eczema

Industry news / 13 July 2015 / Victoria White

Anacor has announced positive preliminary top-line results from its two Phase 3 pivotal studies of crisaborole in atopic dermatitis (eczema)…